Dr. Nicole Saphier breaks down the Senate’s rejection of both parties’ proposals to expand ACA subsidies—and explains why she believes lawmakers finally made the right call. Dr. Saphier offers a sharp critique of the Affordable Care Act, arguing that it has empowered insurance companies while driving up costs and reducing care quality for everyday Americans.

She outlines a conservative, patient-centered path forward, including targeted temporary subsidies, expanded Health Savings Accounts, true catastrophic coverage, and the restoration of physician-owned medical centers. With clarity and candor, Dr. Saphier makes the case that only market-driven reforms and a rollback of ACA mandates can restore choice, affordability, and access across the U.S. healthcare system.

Follow Clay & Buck on YouTube: https://www.youtube.com/c/clayandbuck

See omnystudio.com/listener for privacy information.

From October of 2025 - The Best Of The Buck Brief.

After a week in Taiwan meeting with President Lai Ching-te, top military officials, and national security advisors, Buck Sexton breaks down the question everyone’s asking: Is China going to invade Taiwan? From drone factories and missile systems to Taiwan’s vital role in the global chip supply, Buck shares what he learned on the ground and why a Chinese invasion could trigger economic chaos around the world.

Never miss a moment from Buck by subscribing to the Buck Sexton Show Podcast on IHeart Radio, Apple Podcasts or wherever you get your podcasts!

Connect with Buck Sexton:
Facebook – / bucksexton
X – @bucksexton
Instagram – @bucksexton

TikTok - @BuckSexton

YouTube - @BuckSexton

Website – https://www.bucksexton.com/

Follow Clay & Buck on YouTube: https://www.youtube.com/c/clayandbuck

See omnystudio.com/listener for privacy information.

In this eye-opening episode of The Tudor Dixon Podcast, Tudor sits down with author Aimee Donnellan for a deep dive into the meteoric rise of Ozempic—the diabetes drug turned cultural phenomenon for weight loss. Together, they unpack the surprising science behind GLP-1 medications, the growing trend of microdosing, and the real risks users often overlook.

Donnellan and Dixon explore how body image pressures, diet culture, and the powerful food industry fuel America’s obesity crisis. They also discuss why the drug has become both celebrated and controversial, and what its popularity means for the future of weight management.

Follow Clay & Buck on YouTube: https://www.youtube.com/c/clayandbuck

See omnystudio.com/listener for privacy information.